Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma
Philipp K. Haber, Florian Castet, Miguel Torres‐Martín, Carmen Andreu-Oller, Marc Puigvehí, Maeda Miho, Pompilia Radu, Jean‐François Dufour, Chris Verslype, Carolin Zimpel, Jens U. Marquardt, Peter R. Galle, Arndt Vogel, Melanie Bathon, Tim Meyer, Ismaïl Labgaa, Antonia Digklia, Lewis R. Roberts, Mohamed A. Mohamed Ali, Beatriz Mínguez, Davide Citterio, Vincenzo Mazzaferro, Fabian Finkelmeier, Jörg Trojan, Burcin Özdirik, Tobias Müller, Moritz Schmelzle, Anthony Bejjani, Max W. Sung, Myron Schwartz, Richard S. Finn, Swan N. Thung, Augusto Villanueva, Daniela Sia, Josep M. Llovet (2022). Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma. Gastroenterology, 164(1), pp. 72-88.e18, DOI: 10.1053/j.gastro.2022.09.005.
Article363 days agoSingle-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma
Sarah Cappuyns, Marta Piqué‐Gili, Roger Esteban-Fabró, Gino Philips, Ugne Balaseviciute, Roser Pinyol, Albert Gris‐Oliver, Vincent Vandecaveye, Jordi Abril‐Fornaguera, Carla Montironi, Laia Bassaganyas, Judit Peix, Marcus Zeitlhöfler, Agavni Mesropian, Júlia Huguet‐Pradell, Philipp K. Haber, Igor Figueiredo, Giorgio Ioannou, Edgar Gonzalez‐Kozlova, Antonio D’Alessio, Raphael Mohr, Tim Meyer, Anja Lachenmayer, Jens U. Marquardt, Helen L. Reeves, Julien Edeline, Fabian Finkelmeier, Jörg Trojan, Peter R. Galle, Friedrich Foerster, Beatriz Mínguez, Robert Montal, Sacha Gnjatic, David J. Pinato, Mathias Heikenwälder, Chris Verslype, Eric Van Cutsem, Diether Lambrechts, Augusto Villanueva, Jeroen Dekervel, Josep M. Llovet (2024). Single-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma. Journal of Hepatology, DOI: 10.1016/j.jhep.2024.12.016.
Article363 days agoIMbrave050: Phase-3-Studie zur adjuvanten Behandlung mit Atezolizumab+Bevacizumab im Vergleich zur aktiven Überwachung bei Patienten mit hepatozellulärem Karzinom, bei denen nach einer Resektion oder Ablation ein hohes Risiko für ein Wiederauftreten der Krankheit besteht
Jörg Trojan, Pierce K. H. Chow, M. Chen, Ann‐Lii Cheng, Ahmed O. Kaseb, Masatoshi Kudo, H. C. Lee, Adam C. Yopp, Jian Zhou, Lei Wang, Xiaoyu Wen, Jun Heo, Won Young Tak, Shinichiro Nakamura, Kazushi Numata, Thomas Uguen, David Hsieh, Edward Cha, Stephen P. Hack, Qinshu Lian, J. Spahn, Chin‐Lee Wu, Shukui Qin (2023). IMbrave050: Phase-3-Studie zur adjuvanten Behandlung mit Atezolizumab+Bevacizumab im Vergleich zur aktiven Überwachung bei Patienten mit hepatozellulärem Karzinom, bei denen nach einer Resektion oder Ablation ein hohes Risiko für ein Wiederauftreten der Krankheit besteht. , 61(08), DOI: https://doi.org/10.1055/s-0043-1771886.
Article25 days agoTu1483 - Hepatic Safety and Biomarker Assessments in Sorafenibexperienced Patients with Advanced Hepatocellular Carcinoma Treated with Nivolumab in the Checkmate-040 Study
Todd S. Crocenzi, Tim Meyer, Ignacio Melero, Thomas Yau, Chiun Hsu, Masatoshi Kudo, Su Pin Choo, Jörg Trojan, Theodore H. Welling, Yoon‐Koo Kang, Winnie Yeo, Akhil Chopra, Adyb Baakili, Christine Dela Cruz, Huanyu Zhao, Jaclyn Neely, Anthony B. El-Khoueiry, Bruno Sangro (2018). Tu1483 - Hepatic Safety and Biomarker Assessments in Sorafenibexperienced Patients with Advanced Hepatocellular Carcinoma Treated with Nivolumab in the Checkmate-040 Study. , 154(6), DOI: https://doi.org/10.1016/s0016-5085(18)34061-7.
Article25 days agoEfficacy and safety of nivolumab in patients with advanced hepatocellular carcinoma analyzed by patient age: A sub-analysis of the CheckMate 040 study
Ignacio Melero, Anthony B. El-Khoueiry, Thomas Yau, Chiun Hsu, Masatoshi Kudo, Todd S. Crocenzi, Tae‐You Kim, Su Pin Choo, Jörg Trojan, Theodore H. Welling, Yoon‐Koo Kang, Winnie Yeo, Akhil Chopra, Adyb Baakili, Christine Dela Cruz, Huanyu Zhao, Bruno Sangro, Tim Meyer (2017). Efficacy and safety of nivolumab in patients with advanced hepatocellular carcinoma analyzed by patient age: A sub-analysis of the CheckMate 040 study. , 28, DOI: https://doi.org/10.1093/annonc/mdx262.007.
Article25 days ago